94 related articles for article (PubMed ID: 29427922)
1. Psychotomimetic-like behavioral effects of memantine in the mouse.
Kitanaka N; Kitanaka J; Hall FS; Kubota Y; Mimura Y; Ogura S; Okada Y; Uhl GR; Takemura M
Biomed Pharmacother; 2018 Apr; 100():116-123. PubMed ID: 29427922
[TBL] [Abstract][Full Text] [Related]
2. Metoprine, a histamine N-methyltransferase inhibitor, attenuates methamphetamine-induced hyperlocomotion via activation of histaminergic neurotransmission in mice.
Kitanaka N; Hall FS; Kobori S; Kushihara S; Oyama H; Sasaoka Y; Takechi M; Tanaka KI; Tomita K; Igarashi K; Nishiyama N; Sato T; Uhl GR; Kitanaka J
Pharmacol Biochem Behav; 2021 Oct; 209():173257. PubMed ID: 34418452
[TBL] [Abstract][Full Text] [Related]
3. Sigma1 receptor antagonists determine the behavioral pattern of the methamphetamine-induced stereotypy in mice.
Kitanaka J; Kitanaka N; Tatsuta T; Hall FS; Uhl GR; Tanaka K; Nishiyama N; Morita Y; Takemura M
Psychopharmacology (Berl); 2009 May; 203(4):781-92. PubMed ID: 19052726
[TBL] [Abstract][Full Text] [Related]
4. Blockade of brain histamine metabolism alters methamphetamine-induced expression pattern of stereotypy in mice via histamine H1 receptors.
Kitanaka J; Kitanaka N; Tatsuta T; Morita Y; Takemura M
Neuroscience; 2007 Jul; 147(3):765-77. PubMed ID: 17570600
[TBL] [Abstract][Full Text] [Related]
5. Agmatine attenuates methamphetamine-induced hyperlocomotion and stereotyped behavior in mice.
Kitanaka N; Kitanaka J; Hall FS; Uhl GR; Watabe K; Kubo H; Takahashi H; Tanaka K; Nishiyama N; Takemura M
Behav Pharmacol; 2014 Apr; 25(2):158-65. PubMed ID: 24557322
[TBL] [Abstract][Full Text] [Related]
6. Lack of effect of anticonvulsant topiramate on methamphetamine-induced stereotypy and rewarding property in mice.
Tatsuta T; Kitanaka N; Kitanaka J; Morita Y; Takemura M
Pharmacol Biochem Behav; 2007 May; 87(1):48-55. PubMed ID: 17482247
[TBL] [Abstract][Full Text] [Related]
7. The selective μ opioid receptor antagonist β-funaltrexamine attenuates methamphetamine-induced stereotypical biting in mice.
Kitanaka J; Kitanaka N; Hall FS; Uhl GR; Fukushima Y; Sawai T; Watabe K; Kubo H; Takahashi H; Tanaka K; Nishiyama N; Tatsuta T; Morita Y; Takemura M
Brain Res; 2013 Jul; 1522():88-98. PubMed ID: 23727404
[TBL] [Abstract][Full Text] [Related]
8. Distinct dose-dependent effects of methamphetamine on real-time dopamine transmission in the rat nucleus accumbens and behaviors.
Bhimani RV; Vik M; Wakabayashi KT; Szalkowski C; Bass CE; Park J
J Neurochem; 2021 Aug; 158(4):865-879. PubMed ID: 34265079
[TBL] [Abstract][Full Text] [Related]
9. Nitrous oxide and xenon prevent amphetamine-induced carrier-mediated dopamine release in a memantine-like fashion and protect against behavioral sensitization.
David HN; Ansseau M; Lemaire M; Abraini JH
Biol Psychiatry; 2006 Jul; 60(1):49-57. PubMed ID: 16427030
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of stereotyped behavior and production of latent locomotor behaviors in mice treated continuously with quinpirole.
Zhou LW; Qin ZH; Weiss B
Neuropsychopharmacology; 1991 Jan; 4(1):47-55. PubMed ID: 1672250
[TBL] [Abstract][Full Text] [Related]
11. Microdialysis studies with amantadine and memantine on pharmacokinetics and effects on dopamine turnover.
Quack G; Hesselink M; Danysz W; Spanagel R
J Neural Transm Suppl; 1995; 46():97-105. PubMed ID: 8821045
[TBL] [Abstract][Full Text] [Related]
12. Valproate blocks high-dose methamphetamine-induced behavioral cross-sensitization to locomotion-inducing effect of dizocilpine (MK-801), but not methamphetamine.
Ito K; Abekawa T; Koyama T
Psychopharmacology (Berl); 2006 Jul; 186(4):525-33. PubMed ID: 16758239
[TBL] [Abstract][Full Text] [Related]
13. Relationship between development of cross-sensitization to MK-801 and delayed increases in glutamate levels in the nucleus accumbens induced by a high dose of methamphetamine.
Ito K; Abekawa T; Koyama T
Psychopharmacology (Berl); 2006 Aug; 187(3):293-302. PubMed ID: 16850286
[TBL] [Abstract][Full Text] [Related]
14. Changes in cerebral neurotransmitters and metabolites induced by acute donepezil and memantine administrations: a microdialysis study.
Shearman E; Rossi S; Szasz B; Juranyi Z; Fallon S; Pomara N; Sershen H; Lajtha A
Brain Res Bull; 2006 Mar; 69(2):204-13. PubMed ID: 16533671
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment with l-histidine produces a shift from methamphetamine-induced stereotypical biting to persistent locomotion in mice.
Kitanaka J; Kitanaka N; Tatsuta T; Miyoshi A; Koumoto A; Tanaka K; Nishiyama N; Morita Y; Takemura M
Pharmacol Biochem Behav; 2010 Jan; 94(3):464-70. PubMed ID: 19895842
[TBL] [Abstract][Full Text] [Related]
16. Locomotion and stereotyped behaviours induced by 1-amino-3,5-dimethyladamantane (D 145) and apomorphine in the rat: a comparison.
Ljungberg T
J Pharm Pharmacol; 1986 Jul; 38(7):520-5. PubMed ID: 2875153
[TBL] [Abstract][Full Text] [Related]
17. Effects of dopamine antagonists on neuronal histamine release in the striatum of rats subjected to acute and chronic treatments with methamphetamine.
Ito C; Onodera K; Sakurai E; Sato M; Watanabe T
J Pharmacol Exp Ther; 1996 Oct; 279(1):271-6. PubMed ID: 8859003
[TBL] [Abstract][Full Text] [Related]
18. Different effects of the NMDA receptor antagonists ketamine, MK-801, and memantine on postsynaptic density transcripts and their topography: role of Homer signaling, and implications for novel antipsychotic and pro-cognitive targets in psychosis.
de Bartolomeis A; Sarappa C; Buonaguro EF; Marmo F; Eramo A; Tomasetti C; Iasevoli F
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():1-12. PubMed ID: 23800465
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment with nomifensine or nomifensine analogue 4-phenyl-1,2,3,4-tetrahydroisoquinoline augments methamphetamine-induced stereotypical behavior in mice.
Kitanaka J; Kitanaka N; Hall FS; Uhl GR; Asano H; Chatani R; Hayata S; Yokoyama H; Tanaka KI; Nishiyama N; Takemura M
Brain Res; 2012 Feb; 1439():15-26. PubMed ID: 22265332
[TBL] [Abstract][Full Text] [Related]
20. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
LaHoste GJ; Marshall JF
Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
